Lawyers and Settlements
What are you looking for?
Home Page >> Settlements >> GlaxoSmithKline

GlaxoSmithKline

St. Luis, IL: (May-24-07) A settlement has been reached with Britain-based GlaxoSmithKline over a 2004 lawsuit which claimed that the drugmaker promoted the drug, Paxil, to children while withholding information about negative side effects, including increased suicidal behavior. The company agreed to a $64 million class action deal to settle claims. Parents who bought the antidepressant drug, Paxil, for their children may begin seeking reimbursements, provided they furnish proof that they bought GlaxoSmithKline PLC's Paxil and Paxil CR, a controlled-release version of the drug. Parents who no longer have pharmacy records or receipts can get up to $100 refunded by signing a claim form. In agreeing to the settlement, GlaxoSmithKline denies claims that it misled consumers about the medication's safety. [CHICAGO SUN TIMES: PAXIL SETTLEMENT]


Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.

Last updated on Oct-2-08

ARTICLES AND INTERVIEWS

$40 Million Settlement approved in Second Phase of Paxil Class Action: Insurance Companies Reimbursed
$40 Million Settlement approved in Second Phase of Paxil Class Action: Insurance Companies Reimbursed Minneapolis, MN: U.S. Judge Michael J. Davis of the District of Minnesota has approved the final settlement of $40M to reimburse insurance companies, as third-party payers, for their costs in insuring Paxil purchases paid for by the parents of minors prescribed Paxil or Paxil CR [READ MORE]

YOUR STORIES

Publish your experience here for our readers to learn from.



Related Lawsuits

Legal Services:

Facebook





Better Business Bureau

CAALA

Best of the Web Approved

Public Justice
 
FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map

This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2012 Online Legal Media. All rights reserved.